Zymeworks Inc.

ZYME · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market Cap$1,110,395$715,487$512,431$854,437
- Cash$66,103$157,557$400,912$201,867
+ Debt$18,506$26,722$28,113$32,333
Enterprise Value$1,062,798$584,652$139,632$684,903
Revenue$76,304$76,012$412,482$26,680
% Growth0.4%-81.6%1,446%
Gross Profit$76,304-$66,977$412,482$26,680
% Margin100%-88.1%100%100%
EBITDA-$108,624-$120,702$142,490-$206,089
% Margin-142.4%-158.8%34.5%-772.4%
Net Income-$122,695-$118,674$124,341-$211,843
% Margin-160.8%-156.1%30.1%-794%
EPS Diluted-1.62-1.721.9-4.06
% Growth5.8%-190.5%146.8%
Operating Cash Flow-$110,044-$118,303$144,109-$192,451
Capital Expenditures-$3,066-$4,077-$13,125-$13,285
Free Cash Flow-$113,110-$122,380$130,984-$205,736
Zymeworks Inc. (ZYME) Financial Statements & Key Stats | AlphaPilot